BRAF and thyroid cancer: BRAF V600E mutations have been shown to be a sensitive but not specific marker for aggressive thyroid cancers, as they are more likely to be associated with aggressive histopathological features such as capsular invasion, extrathyroidal extension, and nodal metastasis [8,9].